Clik here to view.
フィットビットとJMDC、法人向けFitbit Premiumの日本市場における独占販売契約を締結
東京 （ビジネスワイヤ） — Fitbit, Inc.（本社：米国サンフランシスコ、CEOジェームズ・パーク、以下「フィットビット」）と株式会社JMDC（本社東京都港区、代表取締役社長兼CEO松島陽介、以下「JMDC」）は2020年11月26日、フィットビットの有料会員サービスFitbit Premiumの日本国内の法人向け販売における独占契約を締結いたしました。...
View ArticleClik here to view.
Fitbit and JMDC Sign Agreement to Appoint JMDC as Exclusive Distributor of...
TOKYO Fitbit (NYSE: FIT) today announced that JMDC (TOKYO: 4483) will be the exclusive distributor of Fitbit Premium, Fitbit’s paid membership service, for enterprise customers in Japan. This press...
View ArticleClik here to view.
Fitbit与JMDC签订协议，指定JMDC为日本企业客户的Fitbit Premium独家分销商
东京 (美国商业资讯)– Fitbit (NYSE: FIT)今天宣布，JMDC (TOKYO: 4483)将成为Fitbit的付费会员服务Fitbit Premium面向日本企业客户的独家分销商。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20201127005245/zh-CN/ image of Fitbit...
View ArticleClik here to view.
Exelixis Announces Partner Takeda Receives Approval in Japan for CABOMETYX®...
ALAMEDA, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that Takeda Pharmaceutical Company Limited (Takeda), its partner responsible for the clinical development and commercialization of...
View ArticleClik here to view.
Takeda Completes Sale of Select OTC and Non-Core Assets to Celltrion in Asia...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products to Celltrion Inc....
View ArticleClik here to view.
Celltrion Completes Acquisition of Primary Care (PC) Product Assets for Asia...
INCHEON, South Korea Celltrion (KRX:068270) has completed the acquisition of select primary care assets from Takeda Pharmaceutical Company Limited (“Takeda”) in Asia Pacific, igniting efforts to...
View ArticleClik here to view.
Lianhua Qingwen Capsules Launched in Philippine Market
SHIJIAZHUANG CITY, China On November 23 local time, the news conference for launching of Lianhua Qingwen Capsules, a Chinese traditional medicine produced by Yiling Pharmaceutical, was held online....
View ArticleClik here to view.
CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New...
TOKYO CureApp, Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Kohta Satake) has announced that CureApp SC Nicotine Addiction Treatment App and CO Checker (hereafter, CureApp SC) – a treatment app (digital...
View ArticleClik here to view.
研究比较机械通气患者液体反应性的两种无创指标，发现MasimoPVi®有效且具有优势
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布《艾因夏姆斯麻醉学杂志》发表的一项研究结果，该研究中，埃及开罗艾因夏姆斯大学(Ain-Shams University)的Diaaeldin Aboelnile博士及其同事比较两种评估机械通气患者液体反应性的无创方法dIVC和Masimo...
View ArticleClik here to view.
人工呼吸器患者におけ輸液反応の非侵襲的指標2種を比較した研究からMasimo PVi®の効果と利点が判明
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ：MASI）は本日、アインシャムス大学（エジプト、カイロ）のDr. Diaaeldin Aboelnileと同僚らがAin-Shams Journal of Anesthesiologyに発表した研究の結果を発表しました。この研究では、人工呼吸器患者におけ輸液反応を評価するための2つの非侵襲的方法、すなわちdIVCとMasimo...
View ArticleClik here to view.
TAITRA Launches Online Medical Show
TAIPEI, Taiwan Taiwan External Trade Development Council (TAITRA), the operator of the nation’s largest B2B portal Taiwantrade.com, has launched the 2020 Medical Online Show. This press release...
View ArticleNew Frontier Health Corporation Announces Third Quarter 2020 Financial Results
BEIJING, China New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH”), today announced its...
View ArticleClik here to view.
Lianhua Qingwen Capsule Obtained Approval in the Philippines, and the Chinese...
SHIJIAZHUANG CITY, China Lianhua Qingwen Capsule, a Chinese traditional medicine made by Yiling Pharmaceutical, has played an important role in China’s COVID-19 prevention and control. The herb...
View ArticleClik here to view.
尼古丁成瘾的数字化疗法CureApp SC：推出基于App的新式处方治疗——首个将被纳入日本公共医保系统的数字化疗法
东京 (美国商业资讯)– CureApp, Inc.（总部：东京都中央区；首席执行官：Kohta Satake）宣布，经过一段时间的临床试验和监管审批，针对尼古丁成瘾的治疗App（数字化疗法）CureApp SC尼古丁成瘾治疗App和CO检查器（下称CureApp SC）现于2020年12月1日纳入日本公共医保系统。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
Independent Discovery Validates Noxopharm’s DARRT Cancer Therapy
SYDNEY Australian clinical-stage drug development company, Noxopharm (ASX: NOX), is pleased to announce that a discovery by Weill Cornell Medical College in New York, recently published in the...
View ArticleClik here to view.
Clik here to view.
Dr. M. Nasar Qureshi Named President of the American Pakistan Foundation
CRANFORD, N.J. Dr. M. Nasar Qureshi, President and Chief Medical Officer of QDx Pathology Services, a national, independent and full-service anatomical and molecular pathology laboratory, has been...
View ArticleClik here to view.
Lianhua Qingwen Selected as Recommended Medicine in China’s Diagnosis and...
SHIJIAZHUANG CITY, China Recently, China’s National Health Commission and State Administration of Traditional Chinese Medicine jointly-published The Diagnosis and Treatment Protocol for COVID-19...
View ArticleClik here to view.
Winners of Taiwan Cultural Memories Photography Competition Revealed
TAIPEI, Taiwan The photos featuring Qinbi Village of Matsu Island and Covid-19 scene have been selected by the Ministry of Culture (MOC) as the top-prize winners of the photography competition for...
View Article